The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2015 | Clinical trials of non-chemotherapy-containing therapies by the German CLL Study Group
At the 20th Congress of the European Hematology Association (EHA), Barbara Eichhorst, MD, of the University of Cologne, Cologne, Germany, summarises clinical trials being conducted by the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) in patients with chronic lymphocytic leukemia (CLL), including a chemotherapy-free treatment with obinutuzumab plus chlorambucil; a watch-and-wait strategy; and a four-arm study comparing standard chemotherapy versus non-chemotherapy-containing regimens.
